- Business Wire•1 hour ago
Incyte Corporation announced today that it has scheduled its fourth quarter and year end 2016 financial results conference call and webcast for 10:00 a.m. ET on Tuesday, February 14, 2017.
- Investor's Business Daily•17 hours ago
The biotech industry has a mixed outlook, but Incyte is one of the few companies with potential blockbuster drugs in its pipeline.
- GlobeNewswire•17 hours agoMerus Announces Closing of Global Strategic Research Collaboration with Incyte to Discover and Develop Bispecific Antibodies
UTRECHT, The Netherlands, Jan. 23, 2017 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ:MRUS) a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced the ...
INCY : Summary for Incyte Corporation - Yahoo Finance
Incyte Corporation (INCY)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||115.00 x 100|
|Ask||122.30 x 200|
|Day's Range||116.74 - 118.82|
|52 Week Range||55.00 - 122.68|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||319.08|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|